Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 3 results.
User Information
Export Records
  1. 1.   Severe Clinical Phenotypes of Heterozygous Females With X-Linked Chronic Granulomatous Disease
  2. Patel, Niraj C; Younger, M Elizabeth M; Williams, Kelli; Matias Lopes, Joao Pedro; Kuhns,Doug; Patel, Meera N; Miranda, Mary Ann; Marciano, Beatriz E; Deal, Christin Lawler; Leiding, Jennifer W
  3. The journal of Allergy and Clinical Immunology. In Practice. 2024, Sep 25;
  1. 2.   X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability
  2. Marciano, Beatriz E; Zerbe, Christa S; Falcone, E Liana; Ding, Li; DeRavin, Suk See; Daub, Janine; Kreuzburg, Samantha; Yockey, Lynne; Hunsberger, Sally; Foruraghi, Ladan; Barnhart, Lisa A; Matharu, Kabir; Anderson, Victoria; Darnell, Dirk N; Frein, Cathleen; Fink, Dani; Lau, Karen; Long-Priel, Debra; Gallin, John I; Malech, Harry L; Uzel, Gulbu; Freeman, Alexandra F; Kuhns, Doug; Rosenzweig, Sergio D; Holland, Steven M
  3. Journal of Allergy and Clinical Immunology. 2018, Jan; 141(1): 365-371.
  1. 3.   HGPRT mutation induction by N-ethyl-N-nitrosourea as measured by 6-thioguanine resistance is higher in male than in female Syrian hamster fetuses
  2. Donovan, P. J.; Smith, G. T.; Dove, L. F.; Klose, J.; Powell, D. A.
  3. Birth Defects Research Part B-Developmental and Reproductive Toxicology. 2006, Oct; 77(5): 399-404.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel